Zhitong Financial APP News, Chen Xin Pharmaceutical (603367.SH) announced that from January to September 2023, after preliminary estimates, the company realized a net profit of 370 million yuan belonging to shareholders of listed companies, an increase of about 26.71 percent compared with the same period last year.
辰欣药业(603367.SH)1至9月预计净利润为3.7亿元，同比增长约26.71%
Chenxin Pharmaceutical (603367.SH) expects net profit of 370 million yuan from January to September, an increase of about 26.71% over the previous year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.